Q3 results confirms that the U.S. vaccine market for respiratory syncytial virus (RSV), led by Pfizer (PFE) and GSK (GSK), is ...
Hosted on MSN2d
Year in Review: RSV
This year's headlines on respiratory syncytial virus (RSV) focused largely on the relatively new vaccines -- including a new ...
Days after Pfizer and BioNTech reported surprisingly strong sales of their updated COVID-19 vaccines, Moderna has done the ...
Residents of Australia’s northern regions have sweltered as a heatwave has continued through the weekend, and is expected to ...
Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...
Dr. Kerry-Anne Perkins, a new mom and board-certified OB-GYN shares what parents need to know about RSV and more.
Just like adults under 60, elderly adults who get RSV tend to have mild symptoms, such as runny nose, sore throat, cough, ...
GSK has received Canadian approval for its respiratory syncytial virus vaccine in adults between 50 and 59, the company said ...
Mums and their newborns will now have free access to protection against RSV. Added13 minutes ago An experienced flat-track motorbike rider has died after a crash at an Adelaide speedway on the opening ...
The Royal Australian College of GPs (RACGP) has lauded the Federal Government's announcement of $174.5 million to provide free RSV vaccination during ...
The Australian government has said it will make vaccination against respiratory syncytial virus (RSV) free for newborns and pregnant women starting in 2025. Mark Butler, the minister for health, on ...
Moderna (MRNA) announced Health Canada has approved mRESVIA for active immunization for the prevention of lower respiratory tract disease caused by respiratory syncytial virus in adults 60 years of ...